HSBC Holdings
LENZ

HSBC Holdings’s LENZ Therapeutics LENZ Stock Holding History

HSBC Holdings’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$449K Buy
79,811
+57,917
+265% +$467K ﹤0.01% 2333
2026
Q1 		$204K Buy
+21,894
New +$308K ﹤0.01% 2606
2024
Q1 		– Sell
-3,124
Closed -$57.7K – 3269
2023
Q4 		$57.7K Buy
3,124
+16
+0.5% +$264 ﹤0.01% 2638
2023
Q3 		$52.2K Buy
+3,108
New +$54K ﹤0.01% 2621

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
7IH
72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

HSBC Holdings's LENZ Position: Q2 2026 in Review

HSBC Holdings increased its LENZ Therapeutics (LENZ) stake by 265% in Q2 2026, buying an estimated $467K and bringing the position to 79,811 shares worth $449K. The position accounts for ﹤0.01% of the portfolio, ranked #2333.

HSBC Holdings first reported a position in LENZ in Q3 2023 and has held it in 4 quarters since. 144 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

  • HSBC Holdings held 79,811 shares of LENZ Therapeutics worth $449K as of Q2 2026.
  • HSBC Holdings bought 57,917 LENZ Therapeutics shares in Q2 2026, an estimated $467K.
  • LENZ Therapeutics made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2333 holding.
  • HSBC Holdings first reported a position in LENZ Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • 144 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.